In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands

Neuropsychopharmacology

Volumn 17, Issue 5, 1997, Pages 293-307

  Kegeles, Lawrence S ^a,b   Mann, J John ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Box # 28 ^*  (United States)

Author keywords

Brain imaging; Ligands; Neuroreceptors; Neurotransmitters; Positron emission tomography; Single photon emission computed tomography

Indexed keywords

BRAIN BLOOD FLOW; BRAIN METABOLISM; DIAGNOSTIC IMAGING; HUMAN; ISOTOPE LABELING; MENTAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030830518     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00069-9     Document Type: Article

References (123)

1. Abi-Dargham A, Lamelle M, Seibyl J, Rattner Z, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Bremmer JD, Hyde TM, Charney DS, Hoffer PB, Innis RB (1994): SPECT measurements of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms. J Nucl Med 35:228-238
2. 11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers. Acta Psychiatr Scand 83:449-455
3. 2 receptors in the human neostriatum. Schizophr Bull 14:471-484
4. Andreasen NC, Rezai K, Alliger R, Swayze VW 2nd, Flaum M, Kirchner P, Cohen G, O'Leary DS (1993): Hypofrontality in neuroleptic-naive and chronic schizophrenic patients: assessment with xenon-133 single photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49:943-958
5. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinck H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A, Cancro R (1994): Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psychiatry 151: 681-686
6. 2 receptors in humans using positron emission tomography. Eur J Nuclear Med 21:937-946
7. 18F]Setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. European Journal of Pharmacology 147:73-82
8. 18F-labelled setoperone. J Neurochem 54:1744-1754
9. 2-receptor blockade by typical and atypical neuroleptics (letter). Lancet 339:497
10. Buchsbaum MS, De Lisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger D, Margolin R, Kessler RM (1984): Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 41:1159-1166
11. Carlsson A (1978): Antipsychotic drugs, neurotransmitters and schizophrenia. Am J Psychiatry 135:165-173
12. Carlsson A (1988): The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186
13. Chugani DC, Ackermann RF, Phelps ME (1988): In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 8:291-303
14. Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Post RM (1989): Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 2:241-254
15. Crow TJ (1983): Is schizophrenia an infectious disease? Lancet 1:173-175
16. Daniel DG, Berman KF, Weinberger DR (1989): The effect of apomorphine on regional cerebral blood flow in schizophrenia. J Neuropsych Clin Neurosci 1:377-384
17. DeLeon M, George A, Ferris S, Rosenbloom S, Christman DR, Gentes CI, Reisberg B, Kricheff TT, Wolf AP (1983): Regional correlations of PET and CT in senile dementia of the Alzheimer type. Am J Neuroradiol 4:553-555
18. Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Morihisa JM (1989): A 'glutamatergic hypothesis' of schizophrenia: rationale for pharmacotherapy with glycine. Clin Neuropharmacol 12:1-13
19. Devous MD, Raese JD, Herman JH, Paulman RG, Gregory RR, Rush AJ, Chehabi HH, Bonte FJ (1985): Regional cerebral blood flow in schizophrenic patients at rest and during Wisconsin card sort tasks. J Cereb Blood Flow Metab 5 (suppl 1):S201-S202
20. 18F]-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse 7:324-327
21. 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780
22. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13:350-356
23. Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, Wolf AP (1993b): Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci USA 90:11816-11820
24. Dewey SL, Smith GS, Logan J, Alexoff D, Ding Y-S, King P, Pappas N, Brodie JD, Ashby CR (1995): Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neuroscience 15:821-829
25. Dudel J, Franke C, Hatt H (1992): Rapid activation and desensitization of transmitter-ligand receptor channels by pulses of agonists. In Narahashi T (ed), Ion Channels, Volume 3. New York, Plenum Press, pp 207-260
26. Eadie GS (1942): The inhibition of cholinesterase by physostigmine and prostigmine. J Biol Chem 146:85-93
27. Erulkar SD (1993): Chemically mediated synaptic transmission: an overview. In Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds), Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 5th ed. New York, Raven Press, pp 181-208
28. 2-dopamine receptor binding in the living human brain by PET. Science 231:258-261
29. 2 receptor increase in PET study of schizophrenia (letter). Arch Gen Psychiatry 44:671-672
30. 2dopamine receptor occupance in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71-76
31. 2-dopamine receptor occupance during treatment with conventional and atypical neuroleptics. Psychopharmacology 99:S28-S31
32. 2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 47:213-219
33. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538-544
34. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16:93-103
35. Fisher RE, Morris ED, Alpert NM, Fischman AJ (1995): In vivo imaging of neuromodulatory synaptic transmis sion using PET: A review of relevant neurophysiology. Human Brain Mapping 3:24-34
36. 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr 4:727-736
37. Frost JJ, Wagner HN (1984): Kinetics of binding of opiate receptors in vivo predicted from in vitro parameters. Brain Res 305:1-11
38. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM (1995): Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 152:341-351
39. Gingrich JA, Caron MG (1993): Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299-321
40. Gjedde A (1981): High-and low-affinity transport of D-glucose from blood to brain. J Neurochem 36:1463-1471
41. Gjedde A, Wong DF (1990): Modeling neuroreceptor binding of radioligands in vivo. In Frost JJ, Wagner HN (eds), Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes. New York, Raven Press, pp 51-79
42. 2-like receptors are still elevated (letter). Psychiatry Research: Neuroimaging 67:159-162
43. Haldane JBS (1957): Graphical methods in enzyme chemistry. Nature 179:832
44. Hartig PR, Lever J (1990): Serotonin receptors. In Frost JJ, Wagner HN (eds), Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes. New York, Raven Press, pp 153-165
45. 2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 51:116-123
46. Hornykiewicz O, Kish SJ (1987): Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45:19-34
47. Ingvar DH, Franzen G (1974): Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scan 50:452-162
48. 2 receptor in nonhuman primates. Synapse 10:177-184
49. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Wang S, Gao Y, Neumeyer JL, Charney DS, Hoffer PB, Marek KL (1993): Single photon emission computed tomography imaging demonstrates loss of Striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci USA 90:11965-11969
50. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308
51. 11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols. J Neurosci Meth 51:123-134
52. Kawagoe KT, Garris PA, Wiedermann DJ, Wightman RM (1992): Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neuroscience 51:55-64
53. Kendler KS, Diehl SR (1993): The genetics of schizophrenia: a current genetic-epidemiologic perspective. Schizophr Bull 19:261-285
54. 2 receptor radioligands. I. Regional rat brain distribution of iodinated benzamides. J Nucl Med 32:1593-1600
55. Kety SS, Schmidt CF (1948): The nitrous oxide method for quantitative determination of cerebral blood flow in man: theory, procedure, and normal values. J Clin Invest 27:475-483
56. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980): Low cerebrospinal fluid glutamate in schizophrenia patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379-382
57. Kleinman JE, Hyde TM, Herman MM. Methodological issues in the neuropathology of mental illness. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: A Third Generation of Progress. New York, Raven Press, in press
58. 2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Am J Psychiatry 153:183-190
59. 11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. J Cereb Blood Flow Metab 14:85-99
60. Kuhar MJ, Unnerstall JR (1990): Receptor autoradiography. In Yamamura HI, Enna SJ, Kuhar MJ (eds), Methods in Neurotransmitter Receptor Analysis. New York, Raven Press, pp 177-218
61. 4 receptors in human postmortem brain sections: comparison between normals and schizophrenics. Schizophr Res 18:173 (abstract)
62. Langsten JW (1989): Current theories on the cause of Parkinson's disease. J Neurol Neurosurg Psych (special suppl): 13-17
63. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: I. Kinetic modeling of single bolus experiments. J Cereb Blood Flow Metab 14:439-152
64. 2 receptors in healthy subjects. J Nucl Med 35:743-754
65. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, Innis RB (1995): SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36:1182-1190
66. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996): Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Nat Acad Sci USA 93:9235-9240
67. Linnoila M, Virkkunen M, Scheinen M, Nuutila A, Rimon R, Goodwin FK (1983): Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33: 2609-2614
68. 18F]haloperidol binding in baboon and human brain. J Nucl Med 30:898 (abstract)
69. 18F]-N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons. Synapse 9:195-207
70. Mann J, Stanley M, McBride PA, McEwen BS (1986): Increased serotonin-2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954-959
71. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA (1996a): PET imaging of serotonin activation effects on prefrontal cortex in health volunteers. J Cereb Blood Flow Metab 16:418-426
72. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA (1996b): Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 153:174-182
73. Marks IM, Stern R, Mawson D, Cobb J, McDonald R (1980): Clomipramine and exposure for obsessive-compulsive rituals. Br J Psychiatry 136:1-25
74. Maziere B, Loc HC, Baron J-C, Sgouropoulos P, Duquesnoy N, D'Antona R, Cambon H (1985): In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and (76Br)Bromospiperone. Eur J Pharmacol 114:267-272
75. Mazziotta JC (1986): PET studies of local brain metabolism during sensory and motor tasks: strategies, results and applications in neurologic and psychiatric diseases. In Poeck K, Freund HJ, Ganshirt H (eds), Neurology. Berlin, Springer-Verlag, pp 429-440
76. Michaelis L, Menten ML (1913): Die kinetic der invertinwirkung. Biochem Z 49:333-369
77. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ (1984): A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15:217-227
78. Morris ED, Fisher RE, Alpert NM, Rauch SL, Fischman AJ (1995): In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand charac teristics and task length for detection and activation. Human Brain Mapping 3:35-55
79. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neuroscience 15:2186-2191
80. Nasrallah HA, Pettegrew JW (eds) (1995): NMR Spectroscopy in Psychiatric Brain Disorders. Washington, DC, American Psychiatric Press
81. 11C]N-methylspiperone. Psychiatry Res Neuroimaging 61:67-83
82. Olney JW, Farber NB (1995): Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
83. 11C]Ro 151788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET. J Cereb Blood Flow Metab 8:304-313
84. Patlak CS, Blasberg RG, Fenstermacher JD (1983): Graphical evaluation of blood-to-brain transfer constants from multiple-time update data. J Cereb Blood Flow Metab 3:1-7
85. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979): Tomographie measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro2-deoxy-d-glucose: validation of method. Ann Neurol 6:371-388
86. 123I IBZM SPET (single photon emission tomography) study. Psychol Med 23:791-797
87. Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Murray RM, Kerwin RW (1994): Dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study. Br J Psychiatry 164:16-26
88. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiack RS, Brooks DJ (1992): Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study. Ann Neurol 32:151-161
89. Raichle ME (1979): Quantitative in vivo autoradiography with positron emission tomography. Brain Res 1:47-68
90. 15O, II: implementation and validation. J Nucl Med 24:790-798
91. 4 receptor elevation in schizophrenia - fact or artifact? Schizophr Res 18:173 (abstract)
92. 3H-(-)-N-n-propylnorapomorphine in mouse brain. Naunyn Schmiedebergs Arch Pharmacol 340:13-20
93. 2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F] altanserin: results in young normal controls. J Cereb Blood Flow Metab 15:787-797
94. Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L (1988): In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2:863-866
95. Scatchard G (1949): The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672
96. Scheffel U (1993): In vivo brain receptor imaging. J Clin Immunoassay 16:300-310
97. Schultz W, Ruffieux A, Aebischer P (1983): The activity of pars compacta neurons of the monkey substantia nigra in relation to motor activation. Exp Brain Res 252:810-816
98. 1-dopamine Receptors. New York, Plenum, pp 119-124
99. Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordstrom A-L, Nyberg S, Pauli S (1995): Utilization of radioligands in schizophrenia research. Clinical Neuroscience 3:112-121
100. 3H]raclopride: Implications for positron emission tomography of the human brain. Synapse 3:96-97
101. 4 receptors elevated in schizophrenia. Nature 365:441-445
102. Seeman P, Sunahara RK, Niznik HB (1994): Receptor-receptor link in membranes revealed by ligand competition: example for dopamine Dl and D2 receptors. Synapse 17:62-64
103. 2 receptors in human subjects with iodine123-IBZM. J Nucl Med 33:1964-1971
104. Sokoloff L, Reivich M, Kennedy C, des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977): The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916
105. 11C](+)McN5652. Synapse 20:37-43
106. Tamminga CA, Dannals RF, Frost JJ, Wong DF, Wagner HN (1993): Neuroreceptor and neurochemistry studies with positron-emission tomography in psychiatric illness: promise and progress. In Review of Psychiatry, Vol 12. Washington, DC, American Psychiatric Press, pp 487-510
107. Volkow ND, Fowler JS (1992): Neuropsychiatrie disorders: Investigations of schizophrenia and substance abuse. Semin Nucl Med 22:254-267
108. 11C]-raclopride in the human brain. Synapse 16:255-262
109. Votaw JR, Kessler RM, de Paulis T (1993): Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide. Synapse 15:177-190
110. Wagner HN, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, Frost JJ, Raert HT, Links JM, Rosenblom SB, Lukas SE, Kramer AV, Kuhar MJ (1983): Imaging dopamine receptors in the human brain by positron tomography. Science 221:1264-1266
111. Weinberger DR (1986): The pathogenesis of schizophrenia: a neurodevelopmental theory. In Nasrallah HA, Weinberger DR (eds), Handbook of Schizophrenia I: The Neurology of Schizophrenia. Amsterdam, Elsevier Science Publishers, 1:397-406
112. Weinberger DR, Berman KF, Zee RF (1986): Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional blood flow evidence. Arch Gen Psychiatry 43:114-124
113. 11C]tyrosine and PET. J Nucl Med 32:2043-2049
114. Wolkin A, Barouche F, Wolf AP, Rotrosen J, Fowler JS, Shiue C-Y, Cooper TB, Brodie JD (1989a): Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. Am J Psychiatry 146: 905-908
115. Wolkin A, Brodie JD, Barouche F, Rotrosen J, Wolf AP, Smith M, Fowler J, Cooper TB (1989b): Dopamine receptor occupancy and plasma haloperidol levels. Arch Gen Psychiatry 46:482-483
116. Wong DF, Wagner HN, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JKT, Burns HD, Kuhar MJ (1984): Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226:1393-1396
117. Wong DF, Gjedde A, Wagner HN, Dannals RF, Douglass KH, Links JM, Kuhar MJ (1986a): Quantification of neuroreceptors in living human brain, II: inhibition studies of receptor density and affinity. J Cereb Blood Flow Metab 6:147-153
118. 2 dopamine receptors in drug-naive schizophrenics. Science 234:1558-1563
119. 11C-Methyl)-2-Br-LSD. Synapse 1:393-398
120. Wong DF, Young LT (1991): Quantification of human neuroreceptors in neuropsychiatric disorders with positron-emission tomography. In Volkow ND, Wolf AP (eds), Positron-Emission Tomography in Schizophrenia Research. Washington, DC, American Psychiatric Press, pp 101-124
121. 11C]WIN 35,428. Synapse 15:130-142
122. Young AB, Frey KA, Agranoff BW (1986): Receptor assays: In vitro and in vivo. In Phelps ME, Mazziotta JC, Schelbert HR (eds), Positron Emission Tomography and Autoradiography. Principles and Applications for the Brain and Heart. New York, Raven Press, pp 73-111
123. Young WS, Kuhar MJ (1980): Serotonin receptor localization in rat brain by light microscopic autoradiography. Eur J Pharmacol 62:237-239